Procoagulant effects of intraocular sodium hyaluronate (Healon) after phakic diabetic vitrectomy. A prospective, randomized study

Ophthalmology. 1989 Oct;96(10):1491-4. doi: 10.1016/s0161-6420(89)32686-8.

Abstract

A procoagulant effect was reported previously after injection of 0.50 to 0.75 ml of sodium hyaluronate (Healon) into the vitreous cavity at the end of phakic diabetic vitrectomies. A multicenter, randomized, prospective trial was done to study this effect. In the treatment group the media was clear in 50% of eyes in the immediate postoperative period compared with only 8% in the control group. At 2 to 6 weeks, there was no statistically significant difference between the two groups. The authors conclude that such sodium hyaluronate injection provides clear media in a significant number of eyes in the immediate postoperative period, potentially allowing thorough postoperative evaluation and early retinal photocoagulation if needed.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Coagulants / adverse effects
  • Coagulants / therapeutic use*
  • Diabetic Retinopathy / surgery*
  • Humans
  • Hyaluronic Acid / adverse effects
  • Hyaluronic Acid / pharmacology*
  • Intraocular Pressure / drug effects
  • Middle Aged
  • Multicenter Studies as Topic
  • Postoperative Care
  • Prospective Studies
  • Random Allocation
  • Vitrectomy* / adverse effects
  • Vitreous Hemorrhage / drug therapy
  • Vitreous Hemorrhage / etiology

Substances

  • Coagulants
  • Hyaluronic Acid